跳至主要内容
临床试验/NCT03776825
NCT03776825Unknown不适用

Use of Permacol Paste in Perianal Crohn's Disease

Istituto Clinico Humanitas1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2019年2月7日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
1
主要终点
Perianal fistula closure rate

研究概览

简要总结

The purpose of this study is to collect data about the efficacy of Permacol Paste treatment in perianal Crohn's Disease.

详细描述

This is an observational prospective cohort study aimed to assess the efficacy of Permacol Paste treatment in perianal Crohn's Disease, by evaluating the healing rate and quality of life of 20 patients prospectively indicated to Permacol Paste treatment during one year.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18, any sex
  • Diagnosis of CD at least 6 months earlier in accordance with clinical, endoscopic, histological an/or radiological criteria
  • Presence of perianal fistulas with maximum 3 external openings and a maximum of 2 internal openings, assessed by physical examination and MRI
  • Non-active or mildly active luminal CD defined by a CDAI < 220

排除标准

  • CDAI > 220
  • Dominant luminal active CD requiring immediate surgical or medical therapy
  • Fistula with > 3 external openings and > 2 internal openings
  • Severe active proctitis and/or rectal stenosis
  • Abscess or pelvic collection > 2 cm diameter
  • Concomitant rectovaginal fistulas
  • Concomitant steroid treatment or treated with steroids in the last 4 weeks

结局指标

主要结局

Perianal fistula closure rate

时间窗: 12 months

Complete fistula closure will be defined as absence of spontaneous suppuration or suppuration on applying gentle pressure

次要结局

  • Patients quality of life(12 months)
  • Patients continence(12 months)

研究者

发起方
Istituto Clinico Humanitas
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验